Please assess the completion status of the following clinical trial:

Trial Title: Nonconvulsive Electrotherapy: a Proof-of-concept Trial

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Men and women, aged 18 years and older meeting structured clinical interview for the DSM IV (SCID) criteria for unipolar major depressive disorder, bipolar disorder, or schizoaffective disorder.~2. Subjects of child-bearing potential must agree to have a pregnancy test prior to enrollment and agree to use a reliable method of birth-control during the study.~3. Willingness and ability to provide informed consent as determined by satisfactorily completing the study-specific Evaluation to Sign Consent Form Test.~4. Baseline score ≥ 16 on the 21-item version of the Hamilton Depression Rating Scale (HAMD-21) for unipolar depression, the Bipolar Depression Rating Scale (BDRS) for bipolar depression, or the Young Mania rating scale (YMRS) for mania.~5. Willingness to allow the Principal Investigator to discuss study participation with treating psychiatrist~6. Taking the same regimen of psychiatric medications with no changes for at least one month prior to NET treatment and willingness to not have any medication changes during NET treatment.~7. Currently an outpatient.~8. History of or currently refusing ECT due to experience of or anticipation of adverse effects.~Exclusion Criteria:~1. Pregnancy.~2. Use of any investigational drugs within 30 days of baseline or at any time during the study.~3. Ongoing substance abuse or dependence.~4. Current suicidal ideas.~5. Presence of any condition that would contraindicate ECT or bifrontal electrode placement.~6. Medical or neurologic condition etiologically related to mood disorder.~7. History of coronary artery disease or cardiac arrhythmia.~8. History of serious, potentially life-threatening reaction to anesthesia.~9. For individuals who need to have brain imaging, presence of metal in the body that would make a head MRI unsafe.~10. For individuals who need to have brain imaging, history of claustrophobia or anxiety associated with previous MRI.~11. Allergy or adverse reaction to methohexital or succinylcholine.~12. Epilepsy or seizure disorder.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Nonconvulsive electrotherapy (Type: EXPERIMENTAL): Open label single arm study of nonconvulsive electrotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).